A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.
Clinical trial NCT00651365 · TERMINATED
Trial details
- NCT number
- NCT00651365
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.